Literature DB >> 12971800

Urinary sulfur-containing metabolite produced by intestinal bacteria following oral administration of dimethylarsinic acid to rats.

Kaoru Yoshida1, Koichi Kuroda, Xu Zhou, Yoshinori Inoue, Yukiko Date, Hideki Wanibuchi, Shoji Fukushima, Ginji Endo.   

Abstract

Our long-term oral administration of dimethylarsinic acid (DMAV) in rats revealed that three unidentified metabolites, M-1, M-2, and M-3, were detected in urine and feces. DMAV and trimethylarsine oxide (TMAO) were converted to M-2 and M-3 and M-1 by Escherichia coli strain A3-6 isolated from the ceca of DMAV-administered rats, respectively. In this study, we report on the mechanism of production and the chemical properties of these unknown metabolites. To investigate the pattern of conversion of DMAV or TMAO by A3-6 in the presence of cysteine (Cys), arsenic metabolites of DMAV or TMAO in medium after incubation with A3-6 and Cys were analyzed by liquid chromatography with inductively coupled plasma mass spectrometry (LC-ICP-MS). DMAV was reduced to dimethylarsinous acid (DMAIII) to form M-2 in the presence of Cys and A3-6, and M-2 was further converted to M-3. TMAO was rapidly converted to M-1 by A3-6. The cytotoxicity of the unidentified metabolites was investigated. M-2 was more cytotoxic than DMAV, M-1, and M-3 in V79 cells. The cytotoxicity of M-2 in HL-60 cells was decreased by the addition of superoxide dismutase, suggesting that the cytotoxicity of M-2 might be due to the production of reactive oxygen species. In addition, we examined the chemical properties of M-2 by LC-ICP-MS and LC-MS. M-2 was oxidized to DMAV by hydrogen peroxide, suggesting that M-2 may be a reduced form of DMAV. M-2 was consistent with the reactant of DMAV with metabisulfite-thiosulfate reagent but not DMAIII by analyses of LC-ICP-MS and LC-MS. The molecular weight of M-2 was 154, and M-2 was a sulfur-containing metabolite.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12971800     DOI: 10.1021/tx030008x

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

Review 1.  Xenobiotics: Interaction with the Intestinal Microflora.

Authors:  Kun Lu; Ridwan Mahbub; James G Fox
Journal:  ILAR J       Date:  2015

Review 2.  Human exposure to organic arsenic species from seafood.

Authors:  Vivien Taylor; Britton Goodale; Andrea Raab; Tanja Schwerdtle; Ken Reimer; Sean Conklin; Margaret R Karagas; Kevin A Francesconi
Journal:  Sci Total Environ       Date:  2016-12-24       Impact factor: 7.963

3.  Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification.

Authors:  Yulan Wang; Elaine Holmes; Jeremy K Nicholson; Olivier Cloarec; Jacques Chollet; Marcel Tanner; Burton H Singer; Jürg Utzinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

4.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Sean D Conklin; John T Creed; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

5.  Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice.

Authors:  Klaus Michalke; Annette Schmidt; Britta Huber; Jörg Meyer; Margareta Sulkowski; Alfred V Hirner; Jens Boertz; Frank Mosel; Philip Dammann; Gero Hilken; Hans J Hedrich; Martina Dorsch; Albert W Rettenmeier; Reinhard Hensel
Journal:  Appl Environ Microbiol       Date:  2008-03-31       Impact factor: 4.792

6.  Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils.

Authors:  Tom Van de Wiele; Christina M Gallawa; Kevin M Kubachka; John T Creed; Nicholas Basta; Elizabeth A Dayton; Shane Whitacre; Gijs Du Laing; Karen Bradham
Journal:  Environ Health Perspect       Date:  2010-03-26       Impact factor: 9.031

7.  Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.

Authors:  Baowei Chen; Fenglin Cao; Chungang Yuan; Xiufen Lu; Shengwen Shen; Jin Zhou; X Chris Le
Journal:  Anal Bioanal Chem       Date:  2013-01-15       Impact factor: 4.142

8.  The Investigation of Unexpected Arsenic Compounds Observed in Routine Biological Monitoring Urinary Speciation Analysis.

Authors:  Elizabeth Leese; Malcolm Clench; Jackie Morton; Philip H E Gardiner; Vikki A Carolan
Journal:  Toxics       Date:  2017-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.